Ogura Y - Search Results

1

Progression of age-related macular degeneration in eyes with abnormal fundus autofluorescence in a Japanese population: JFAM study report 3.

Oshima Y, Shinojima A, Sawa M, Mori R, Sekiryu T, Kato A, Hara C, Saito M, Sugano Y, Hirano Y, Asato H, Nakamura M, Kimura E, Yuzawa M, Ishibashi T, Ogura Y, Iida T, Gomi F, Yasukawa T. Oshima Y, et al. Among authors: ogura y. PLoS One. 2022 Feb 25;17(2):e0264703. doi: 10.1371/journal.pone.0264703. eCollection 2022. PLoS One. 2022. PMID: 35213672 Free PMC article.

2

[Clinical dose finding study of indocyanine green to detect choroidal neovascularization in patients with exudative age-related macular degeneration].

Yuzawa M, Yoneya S, Uyama M, Takahashi K, Takeda M, Shiraga F, Miki T, Shiraki K, Hayashi K, Ogura Y, Komemushi S, Matsui M. Yuzawa M, et al. Among authors: ogura y. Nippon Ganka Gakkai Zasshi. 2002 Feb;106(2):89-98. Nippon Ganka Gakkai Zasshi. 2002. PMID: 11915378 Clinical Trial. Japanese.

3

Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ogura Y. Yasukawa T, et al. Among authors: ogura y. Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):672-8. doi: 10.1007/s00417-002-0484-9. Epub 2002 Jul 12. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 12192462

4

Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.

Okabe J, Kimura H, Kunou N, Okabe K, Kato A, Ogura Y. Okabe J, et al. Among authors: ogura y. Invest Ophthalmol Vis Sci. 2003 Feb;44(2):740-4. doi: 10.1167/iovs.02-0375. Invest Ophthalmol Vis Sci. 2003. PMID: 12556407

5

Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device.

Okabe K, Kimura H, Okabe J, Kato A, Kunou N, Ogura Y. Okabe K, et al. Among authors: ogura y. Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2702-7. doi: 10.1167/iovs.02-0956. Invest Ophthalmol Vis Sci. 2003. PMID: 12766076

6

Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.

Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y. Kato A, et al. Among authors: ogura y. Invest Ophthalmol Vis Sci. 2004 Jan;45(1):238-44. doi: 10.1167/iovs.02-1258. Invest Ophthalmol Vis Sci. 2004. PMID: 14691179

7

Drug delivery systems for vitreoretinal diseases.

Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Yasukawa T, et al. Among authors: ogura y. Prog Retin Eye Res. 2004 May;23(3):253-81. doi: 10.1016/j.preteyeres.2004.02.003. Prog Retin Eye Res. 2004. PMID: 15177203 Review.

8

Effect of benzalkonium chloride on transscleral drug delivery.

Okabe K, Kimura H, Okabe J, Kato A, Shimizu H, Ueda T, Shimada S, Ogura Y. Okabe K, et al. Among authors: ogura y. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):703-8. doi: 10.1167/iovs.03-0934. Invest Ophthalmol Vis Sci. 2005. PMID: 15671302

9

Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.

Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Nozaki M, Ogura Y. Kato A, et al. Among authors: ogura y. Retina. 2005 Jun;25(4):503-9. doi: 10.1097/00006982-200506000-00017. Retina. 2005. PMID: 15933599

10

Intraocular sustained drug delivery using implantable polymeric devices.

Yasukawa T, Ogura Y, Sakurai E, Tabata Y, Kimura H. Yasukawa T, et al. Among authors: ogura y. Adv Drug Deliv Rev. 2005 Dec 13;57(14):2033-46. doi: 10.1016/j.addr.2005.09.005. Epub 2005 Nov 2. Adv Drug Deliv Rev. 2005. PMID: 16263193 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,798 results

Search Page